PHP
NSTG

Parkman Healthcare Partners’s NanoString Technologies, Inc. NSTG Stock Holding History

Parkman Healthcare Partners’s Portfolio NSTG Stock Details NSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-187,500
Closed -$759K – 116
2023
Q2 		$759K Buy
+187,500
New +$1.38M 0.13% 89
2022
Q4 		– Sell
-242,600
Closed -$3.1M – 99
2022
Q3 		$3.1M Buy
+242,600
New +$3.37M 0.88% 42

Other funds holding NSTG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Parkman Healthcare Partners's NSTG Position: Q3 2023 in Review

Parkman Healthcare Partners sold out of NanoString Technologies, Inc. (NSTG) in Q3 2023, closing a stake of 187,500 shares — an estimated $759K sold.

Parkman Healthcare Partners first reported a position in NSTG in Q3 2022 and held it in 2 quarters. The position peaked at $3.1M in Q3 2022. 117 funds tracked by Wall St. Rank hold NSTG as of Q3 2023.

  • Parkman Healthcare Partners reported no remaining NanoString Technologies, Inc. position as of Q3 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 187,500 NanoString Technologies, Inc. shares in Q3 2023, an estimated $759K.
  • Parkman Healthcare Partners first reported a position in NanoString Technologies, Inc. in Q3 2022 and held it in 2 quarters.
  • Parkman Healthcare Partners's NanoString Technologies, Inc. position peaked at $3.1M in Q3 2022.
  • 117 funds tracked by Wall St. Rank held NanoString Technologies, Inc. as of Q3 2023.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.